Publisher
Springer International Publishing
Reference42 articles.
1. Annalora AJ, Marcus CB, Iversen PL. Alternative splicing in the cytochrome P 450 superfamily expands protein Diverstiy to Augmewnt gene function and redirect human drug metabolism. Drug Metab Dispos. 2017;45:375–89.
2. Arora V, Knapp DC, Smith BL, Statdfield ML, Stein DA, Reddy MT, Weller DD, Iversen PL. C-Myc antisense limits rat liver regeneration and indicates role for c-myc in regulating cytochrome P-450 3A activity. J Pharmacol Exp Ther. 2000;292:921–8.
3. Bayever E, Haines K, Iversen PL, Ruddon RW, Pirruccello SJ, Mountjoy CP, Arneson MA, Smith LJ. Selective cytotoxicity of human leukemic Myeloblasts produced by Oligodeoxyribonucleic Phosphorothioate complementary to p 53 nucleotide sequences. Leuk Lymphoma. 1993a;12:223–31.
4. Bayever E, Iversen PL, Bishop M, Sharp JG, Tewary HK, Arneson MA, Pirruccello SJ, Ruddon RW, Kessinger A, Zon G, Armitage JO. Systemic administration of a Phosphorothioate oligonucleotide with a sequence complementary to p 53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial. Antisense Res Dev. 1993b;3:383–90.
5. Copple BL, Gmeiner WM, Iversen PL. Reaction between metabolically activated acetaminophen and Phosphorothioate oligonucleotides. Toxicol Appl Pharmacol. 1995;133:53–63.